Search for: "Buchanan Ingersoll "
Results 41 - 60
of 220
Sorted by Relevance
|
Sort by Date
15 Nov 2023, 3:15 pm
RatnerPrestia Is Merging with Buchanan Ingersoll: Cheers to growth! [read post]
14 Sep 2015, 8:30 pm
Sequenom David Stein: Most Dangerous Problem In Patent Law Michal Addady: Why Burning Man Could Be Suing Quiznos Joseph Mandour: Apple Suffers Patent Invalidation In Samsung Case Get a Job doing Patent Law Buchanan Ingersoll & Rooney PC Reinhart Boerner Van Deuren s.c. [read post]
3 Aug 2010, 2:00 am
Lewis) (Buchanan Ingersoll & Rooney, Washington, D.C.), pp. 3, From the Chair-Elect (Charles... [read post]
29 Jan 2010, 10:00 am
Lewis) (Buchanan Ingersoll & Rooney, Washington, D.C.) [read post]
29 Apr 2010, 1:31 am
Lewis) (Buchanan Ingersoll... [read post]
10 Aug 2009, 3:00 am
Lewis (Buchanan Ingersoll & Rooney, Washington, D.C.) [read post]
20 Oct 2022, 6:09 am
“Buchanan Ingersoll Has No Conflict of Interest in Employment Dispute, Pa. [read post]
31 Jan 2015, 3:20 am
TurnerBoyd in Silicon Valley MBHB in Chicago Buchanan Ingersoll in DC Area NSIP Law in DC Area Hickman Palermo in Silicon Valley Roberets Mlotkowski in Tyson’s Corner Ladas & Parry in LA Klintworth & Rozenblat open to remote work Roche in Pleasanton CA Arnold & Porter in DC Area Levine Bagade Han in Silicon Valley Holland & Hart in their Various Offices [Posting I] [Posting II] [Posting III] Naval Air Warfare Center in California Questions? [read post]
17 Dec 2008, 6:28 pm
The paper reported that Buchanan Ingersoll & Rooney's Barry Slotnick--he of New York subway vigilante lore--flew down to the wealthy enclave from New York on a client's private plane. [read post]
4 Feb 2017, 8:06 pm
Bowser of Buchanan Ingersoll & Rooney PC, and Vivek Ganti of Hill, Kertscher & Wharton, LLP will provide attendees with practice tips for post-grant validity proceedings. [read post]
6 Nov 2021, 9:15 pm
., Jay Tatachar of Ericsson, Vaishali Udupa of Hewlett Packard Enterprise, Todd Walters of Buchanan Ingersoll & Rooney PC, and Jenifer Ward General Electric Co. will discuss the pros and cons of the various options for challenging the validity of patent claims, giving perspectives from both challenger and patent owner, and highlight... [read post]
4 Sep 2016, 8:39 pm
– Patrick Keane of Buchanan Ingersoll & Rooney PC and Joerg-Uwe Szipl of Griffin and Ezipl, P.C. will moderate a panel consisting of Tom Krause, Deputy Solicitor, U.S. [read post]
24 May 2020, 8:20 pm
Patrick Keane of Buchanan Ingersoll & Rooney PC will moderate a panel consisting of Uren Chen of Qualcomm Inc.; Ron Dimock of Gowling WLG; Laura Sheridan of Google LLC; and Coke Stewart, Acting Chief of Staff and Senior Policy Advisor, U.S. [read post]
5 Aug 2017, 8:45 pm
Stewart, III of Buchanan Ingersoll & Rooney will provide guidance to patent counsel on the use of the patent prosecution highway and other ways to fast track examination; examine the pros and cons of options and will discuss factors to consider when determining whether to pursue accelerated prosecution and which avenue to take; and... [read post]
28 Jul 2018, 8:24 pm
Stewart, III of Buchanan Ingersoll & Rooney will provide guidance to patent counsel on the use of the Patent Prosecution Highway (PPH) and other ways to fast track examination, examine the pros and cons of options and discuss factors to consider when determining whether to pursue accelerated prosecution and which avenue to take, and... [read post]
9 Feb 2019, 9:49 pm
Lee of Buchanan Ingersoll & Rooney will provide guidance on Section 112 issues that arise during an inter partes review (IPR) proceeding, address the PTAB's response to assertions that claims do not comply with § 112, discuss related claim construction... [read post]
10 Mar 2018, 9:13 pm
Fedowitz, and Mythili Markowski of Buchanan Ingersoll & Rooney will discuss strategies for using IPRs in relation to Hatch-Waxman litigation, how pharmaceutical patents fare in post-grant challenges in comparison to all patents, and what the crucial issues are in post-grant challenges involving pharmaceutical patents. [read post]
3 Sep 2019, 5:59 am
., law firm that plans to try to provide answers later this month.The firm, Buchanan Ingersoll & Rooney, said it will stage a webinar on Sept. 17 to explain Food and Drug Administration "regulations and enforcement, and how stem cell stakeholders (pharma/biotech companies, healthcare providers) can best comply. [read post]
1 May 2021, 9:39 pm
Keane of Buchanan Ingersoll & Rooney PC will moderate a panel consisting of Charles Eloshway, Senior Patent Counsel, Office of Policy and International Affairs (OPIA), United States Patent and Trademark Office; Konstantinos Georgaras, Chief Executive Officer (Interim) of the Canadian Intellectual Property Office; Thomas Krause, Deputy General Counsel for Intellectual Property Law and Solicitor, United States Patent and Trademark Office. [read post]
27 May 2018, 8:43 pm
Cherry of Buchanan Ingersoll & Rooney will guide patent counsel on the use of secondary considerations at the Patent Trial and Appeal Board (PTAB), examine what works and what does not when seeking to defeat validity challenges, review Federal Circuit decisions addressing secondary considerations evidence presented in an IPR trial, and offer best practices for arguing secondary considerations at the PTAB. [read post]
